卵母细胞捐献者中使用可丽康α促排卵与常规每日促性腺激素的经济影响:一项随机研究
该研究基于多中心、前瞻性、随机研究数据,在IVI集团三家私立诊所的卵母细胞捐献项目中开展经济评估,比较可丽康α与常规每日促性腺激素促排卵的经济影响。结果显示两组临床变量无相关差异,可丽康α增加了治疗总成本及每枚获取和有效卵母细胞的成本,但差异未达统计学显著。
要点
- 可丽康α促排卵增加治疗总成本及每枚获取和有效卵母细胞的成本,但差异未达统计学显著。
- 两组临床变量无相关差异。
- 使用较便宜的促性腺激素进行促排卵可节省成本,决策时应考虑可丽康α与重组FSH及高纯度人绝经期促性腺激素的成本。
核心结论
- 使用较便宜的促性腺激素进行促排卵可节省成本。
- 决策时应考虑可丽康α与重组FSH及高纯度人绝经期促性腺激素的成本。
研究设计与样本
- 基于多中心、前瞻性、随机研究数据的经济评估,研究在IVI集团三家私立诊所的卵母细胞捐献项目中进行。
主要发现
- 两组临床变量无相关差异。
- 可丽康α促排卵增加治疗总成本及每枚获取和有效卵母细胞的成本,但差异未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Assisted reproductive technologies are well-established treatments for many types of subfertility representing substantial economic and healthcare implications for patients, healthcare providers and society as a whole. In order to optimize outcomes according to the type of gonadotrophins within an oocyte donor programme, we performed an economic evaluation based on data collected in a multicentre, prospective, randomized study within three private clinics belonging to the IVI Group. Results showed no relevant between-group differences in the clinical variables. According to the economic analysis, ovarian stimulation with corifollitropin alfa increased the overall cost of the treatment as well as the cost per retrieved and effective oocyte, although the differences were not statistically significant. In conclusion, cost savings can be achieved using cheaper gonadotrophins during ovarian stimulation. The cost of corifollitropin alfa compared with recombinant FSH and highly purified human menopausal gonadotrophin should be considered when making treatment decisions.
引用
- Cruz M, Alamá P, Muñoz M, et al. Economic impact of ovarian stimulation with corifollitropin alfa versus conventional daily gonadotropins in oocyte donors: a randomized study. Reprod Biomed Online. 2017. PMID: 28366518. doi:10.1016/j.rbmo.2017.03.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。